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ad tbp~mnsequrnces 2 subs quent rvarrlusion aher thmndwl- 
ysls for BEU,C mywardial iofnirtion hare been wll described. 
eforts to dewrib+ sn&,f,raph,c mnrkerr of lesions n, hl9h risk. for 
reclusion have produced cootlicling REUIIE. The Global Ulilizrt- 
fioa of Skepkddnaor and l-PA far Occluded Curunary Arkrirs 
(GUSTO) sngiographic trial pmtidrs the opporrunity lo o.wuina 
,hw r&dons in the largest singk, pmrpec~w palion, whorl 
smdkd ,o date. 
M&w%. We studinl559 pa,ltn,r uodtrguiog follow-up angiog- 
nphy a, 90 ndo and 5 ,a 1 days &er thmmbolysis in the GUSTO 
Mal. Palltats received qne of four thmndmlytlc regimens: II 
sueptokinssc with irdrnwnws heprin: 2) s,nplaWnase with 
subcuuneon~ hepar@ 3) ~rcclen,~I.dare recomhhmn, lissw 
,ype plamdmyn sc,ivs,or (r&PA) with in,ravrows heparin: or 
4, I m,,,l,hm,ioo of s,rep,okimwe and conwn,iannlly dwed rt-PA 
wllh inlravenws &win. Qualitalive variables examined a, 
?Omia augiupmpbj included Tbnmldysis in hl)wadial lofatc 
liun I flhll) Row gnde. risible Ibmahus and leniuu morphology. 
Qusn,i,a,ire tariah,blcs included pew”, dismeler s,enosis, per- 
PI,,, area stewsis. mioimal lumen diamoler and Lesion leng,h. 
The b,tudj wntninrd II purr >0.85 ,u detect clinically imporao, 
dierancer in percen,diwne,er stenosis, percent UTZ(L stenosir wtd 
ndaimrl huwu divmcler bhwn the groups with subsrquen, 
reocclusiw aad suplaiued pefency a, the p = 0.05 Iewl. 
rhh rrurclurion ws cwn&d nith the group nith &nued 
patency. there were no difkrences in presance of early visible 
lhrumbus. cumplex ltsion q orpholapy, percea, diaoleter stenosis, 
percen, urea stewsis, mioimnl iumen diameter or l&n Ien$h. 
Coaclusiws. Our Bndiops demonrtmtr lha, neither qualitative 
dcpwdmg un regimen utilized. rrwclusion OCCULI in 2% to 29% 
of patisnts (4,6-9). When rcocclusion dces occur, ir is often a 
crtastruphic went. Indeed, in the Tbrombalysis and Angioplasiy 
in Myucardial Infarction (TAMI) trials lhe in-hospital mortality 
rate fur the 12.4% of patients with aaxial reocclusion was 11.0% 
versus 4.5% for the group with continued anerial patency (9). 
Conxouentlv. efforts to idcntifv ~atwNs at highest risk of . I. . 
rccalusion hex been undertaken, usually an the basis of angio- 
graphic features after thrombolyris. However, these effoons hare 
been largely inconclusive. Some groups (10-U) have proposed 
that risk of curonq rcocclusion is related to tie degree of 
residual stenosis. It has also been suggested (12.13) that the 
propensity for reacdusion is greatest in patients ith ulcerated 
lesions or Gsibk thrombus. Snll others (14) bw proposed that 
the quality of coronay Row ar early cathetenzatiai Ls !!x most 
imporlant determinant ofsustained pdtcnq after lh!o!?!bolysis. In 
light of the clinical importance of coronary reocclusion and the 
mn0iaiog data born several reports we am!! 1 the largest data 
baK relwant to this issue, the Global Utilization of Seeptokiw 
and t-PA for G&&d Coronaty Arteries (GUSTO) a”@- 
graphic wdy cohort, to determine whether qualitative 0T quan- 
tit&c engjowhic variables mold be ti to predkt oxonaty 
rwxdusion I a kuge gro”p of patients undergoing early and 
scheduled follow-up an&@y after thromboly&. 
MLdIOdS 
Pltieots. The GUSTO angiographic study (15) was co”- 
ducted in 75 centers in North Ant&a, Europe and Australia 
participating in the GUSTO morta:ity trial (4). These centers 
agreed to enroll all their GUSTO patients in the angiographic 
studv. The entry crireris have bee” orcviouslv dernid (4): 
brie&, the stud; included patients &h ST s&tent &at& 
and symptom duration <6 h. The study was approved by each 
center’s Institutional Review Board and all patients gave 
written informed consent. 
Treatment r”d a”@ogmpltk nndomkatba The thera- 
peutic and angiographic randomization s~ratcgles have tee” 
previously described (4,15). Patients were randomized to one 
of four treatment rcSime”s consisting of 1) strcptokimse 
(Kahbikinasc, Kabi Vihum, Sweden) wilh intravenous hcparfn 
(sodium heparin, Sanoli, Paris), administered as a bolus dose 
of 5,CQO and I,@.?0 Uilt (1,200 U/h for patients weighing 
X30 ke) and adiurtcd to maintain a” aaiwcd martial throm. 
hop@” time bcween 60 ad 80 s; 2) strc~1okinaz.e with 
subcutaneous hnrari” (12.500 U twice dailv bcsi”nina4 h after 
initiation of thro’mm$tie’thcrapy; 3) r&mbi&“t t~wc-ue-rype 
plasminogcn actiwor (n-PA ]Activasc], Genentcch) give” in 
a” accelerated osing regime” with intravenous he& and 
4) a combination arm consisting of streptokinase and conve”. 
tionallv dosed rt-PA with intravenous heoarin. At the time of 
trcatmknt randomization, patients wcrc’alsc randomized lo 
one of four times for initial angiography after thrombolytii 
i”iti&m. 7he time-, were 90 mi” (1,200 patients), 180 min, 
24 h and 5 to 7 days (the latter three groups containing 4fM 
patients each). All pntients enrolled in the 9(Cmi” group were 
also scheduled for follow-up angiography 5 to 7 days later. The 
ttrotocol s&tied that reocelttsion an&is would be oer- 
iomwd in ihe 1,2W patients assigned lo foilow-up angiography 
at 90 mi” and 5 to 7 davs and would exclude “atienls who 
underwent elective angidplasty or bypass swgc& before the 
follow-up an&gram. 
Comnay sngiogmpby sod core rogiogrsphlc latwat~ 
prwdtwes. Infarct-related artery patemy war derermined 
from the first injection of contrast medium. lntmcomnaw 
nitroglycerin (lw to 200 fig) was then administered, and th; 
infaret-related artery was filmed in at least two orthogonal 
projections for quantitative analysis. For each patient enmlkd, 
angiographic ase report forms, cathetetiation laboratory logs 
documenting the angulatio” of all filmed sequenms, catheter 
tips used to inject the infarct-related artery (for calibration I “. .._ . 
Aucs3m.d of Wmin ksiin morphobg) was not a prc- 
sue&cd anal& item but was ~erfomwl in blinded manner in 
ii patients in’whom rcoccht& was subsequently dofttmcnted 
and in 200 consecutive patients with patent vcsacls at W-min 
and 5 to 7-z&y follow-up. Determination of ksion morphology 
was performed utilhing criteria adapted from Ambrose et 4. 
(16): type 0 = asmooth symmetrk lesion; type I = cn eccentric 
kaion with smooth horders; type 2 = an eccentric l&n with 
irregular borders, multiple irregolaritia or tat&m lesions. 
Qualily mntml. Each sile was visited by a core laboratory 
angiographer to ensure adherence to the pmtwal and quan- 
titative angiographic techniques. Every 10th protoe angio 
gram was reanalyzed to assess ntcas”rcmc”t reproducibility. 
Meaawwal repmduelbllily. For quatltilalive mronary 
angiography “sing edge detection, interobser~crvsriabilitywas 
purposes), ctne n”“s ano qua,“ylng eleclrocardlograms were (mea” ? SE) 0.01 ? 0.03 mm for minimal lumen diameter, 
forwarded to the core angiographic laboratory (The George 
Washington University, Washington, D.C.). 
Films wcrc interpreted by an experienced angiogcapher 
who had no knowledge of treatment or an&graphic random- 
ization. The infarct-related artery was r&wed in multiple 
projections, and the site was recorded utilizing a” IS-segment 
coronary artery map. The first injection of the infarct-related 
artery was used to dewrmine the Thmmbolysis in Myocardisl 
Infarction (‘TIMI) flow grade (6): TIM1 grade 0 t3ow = absent 
antemgrade flow beyond the point of obsrmciion: TIM1 grade 
1 flow = Bow beyond the point of obstruction but incomplete 
filling of the distal vcwl; TIMI grade 2 Row = a patent vessel 
with slow filling or slow emptying, or bot!v TIM1 grade 3 
flow = nonndly brisktlow. A definite thmmbvs was detined by 
the prcxncc of adismcte intraluminal filling defect orcon~a~t 
staini”g in the area of the k&et-related stenosis, visible in 
multiple projections. 
Quaa&Uva a”alysir Two orthogonal views of the infarct- 
related artery were digitally acquind and quantitatively ana- 
iyzd “tiling a Tagamo 35AX ckwideo pmjeaor (Tagam” 
AIS. Denmark) Iii thmuah a” ITC RC Viion Plus frame 
gral&cr to a” i&c Contnt &atVlEW workstation. Quantita- 
tiw coronatv analvrb was ncrfomtcd. after manual centerline 
placeme”~ ;til& a tint:and sccoddderfvative dge dctee- 
tio” alnnilbm fARTREK Universiw of MiehieanL &ion _ . _ r 
variables &ained im%cd percent diameter ano&, pxcnt 
arca ~lenosb, minimal lunxe.n diameter and leGon length. For 
dctcmtinalion of percent diawtcr stenosis and percent area 
SIC”&, a “normal” rcferemr segment was idcntifkd pro& 
maltothcste”osis.Whc”twvic!vswerc u!&“icallyadcq”atc. 
the “wt-c were mcarured ste”c& of the fn, view was wed 
for this wiysis. 
Qwmtitatiw cnro”ary analysis utilizing vide&cMitometry 
was perfomted separately utilizing a Vanguard XR-35 tine 
projector linked to a Vanguard XII-70 cutwary analyzer 
(Vattgwd lnstntmcnt Capontion). Reference wegmcna and 
lesion lastion identical to three analyzed by cdgc dc~cction 
were identified by the angiographer, and percent diameter 
stenosis, percent area stenosis and minimal lumen diameter 
were &temGted. 
0.01 + 0.05 mm for normal segment dismeter md 1.0 2 1.1’) 
for percent diameter stenosis. Intraobrrrvcr rariabilio ws 
0.03 2 0.06 mm for minimal lumen diameter. 0.01 ? 0.1 mm 
for normal segment diameter and 1.h ? 1.6% for p+xcent 
diameter stenosis. Combined interobsewr and mrraobswer 
ivs.TlMlgnde3. - 
Assuming a standard deviation of 10’~ for the measure- 
ment of percent dkmetrr rtenusis, 33 p;tticnts&xtp yields B 
paver of 0.86 at the p = 0.0.5 level to detect a difftww in 
percent diameter stenosis at W min uf 7.5% butwccn the 
group with rewclusion and r?st;lined pctency. A standard 
deviation of 0.4 mm for the tneasurctncnt of minimttl lumen 
diameter and 33 patients/group yields a power of 0.86 81 the p 
= 0.05 level to detect a difference of 11.3 mm behwen the 
groups with reocclusion md suswkd paancy. Assuming a 
standard deviation of 6.5% for the mettsuremrnt of percent 
area stenosis. 33 patients/group yields B power Xl.99 IJ detect 
figurn 1. Relation ktuecn coronary reocctwon late and thmmbu. 
tytic a=.+mcnt. No dikences ilre signikunt. SK(W) = atrcptoki- 
n&w with imra~enous hcparin: SK(W) = atmptokinase with sukuta- 
news heparin: t-P* = recumbmrnt tisue-t!pc pl;l\minugen xtiwtur 
(rt-PA) with intravenour huprrin: St-PA tSK = rt-PA and ~trcptoki- 
MX with intravenous hcparin. 
:I dt!kcrencc in percent area stenosis of IO? at tbc p = 0.05 
k\CI. 
St.ttiruc;d analysis was performed with an IBM JS6 com- 
puwr atilziw SAS sofwarc (SAS institute. Inc.). .AII D values 
Results 
Ysticnt chumcteristics. Of the I.210 patienls rnndomized 
tu initial engiography at 90 min. 1,175 ($7’1) undenvcnt the 
procedure. Of this goup, 783 patients had pateot (TIMI Srade 
2 or 3) inhrct-related arteries at a mean of 97 q 12 min after 
initration of thrombolgic therapy. Twenty-seven patients (3%) 
,IUW acludcd from rnalysis because rho an&am was per- 
formed outside the prespecified period of 90 2 45 min. 
anuther 27 patients were excluded becaw uf an elective. 
rwnprutocol ;mgioplasty. 34 (4%) died hefore follow-up and 
I36 (l7?) did not undergo followup bccausc of physician 
refusal (n = IS), pntient refusal (n = 31). clinical status in = 
59) UT ~miwilimcous rc*sons (n = 28). Thus. 559 patients were 
eligible for this analysis. 
Table I Ii>@ the clinical characteristics of the oatients with 
pcrsistcntly patent versus subsequently rec&ded infarct- 
related arteries. There were no significant differences in base- 
lint clinical variables between the two crows. 
Reocctusion by treatment assign&t, kial TIM1 tluw 
grade and time to treatment. Thirty-three piltients (5.9%) had 
kccluded infarct-related coronaky art&s documented at 
follow-up angiography. Figure I displays the reucclusion rittr 
hy treatment assignment which racged from 4.9% to 6.4%. 
Ditkrcnces were not statistically significant. 
The rrw:clusion rate for patients with initial ‘TIMI grade 2 
Row was 6.3% versus 5.6% for patients with initial TIMI grade 
3 flow (p = 0.71). 
The reocclusion rate for the 312 patients (56%) treated 
within 3 h uf pain onset was 5.1% compared with 6.9% for 
those treated >3 h after symptom onset (p = 0.37). 
Quantitative coronary angiograpby. The mean percent 
diameter stentxis, percent art >tenusi*, minimal lumen diam- 
ctw and lesion length at 9tlLmin nngiography for the group 
whose arteries remained patent compnrcd with findings in the 
gruup with subsequent reocclusion is shown in Table 2. None 
of thcsc four angiographic determinants dilkred significantly 
hetwen the two groups. 
The 34 patients who undcment protocol 90.min angiogra- 
phy but died before follow-up did not diUer signiiieantly from 
1hc ,erouo with documented sustained mlencv in ~ercml 
diam~lcr’stenosis (72.4 2 15.8% vs. 70.1 & 13.8%. p = 0.55). 
ocreent area stenosis (89.9 r 10.9% ys. 89.? 2 11.1%. I) = 
b.RZ) or minimal lumen diameter (0.69 C 0.4 mm vs. 0.8b + 
0.4 mm, p = 0.11). 
Figure 2 illustrates the cumulative frequency dis:ribution of 
mini&d lumen diameter at Xl min. There was no signilkant 
difference in incidcn .c of vessels with the smallest resktual 
lumens (i.e., verseIs with minimal lumen diameter 0 lo 0.4 mm 
and 0.4 to 0.8 mm) beween the mows with and wilboul _ 
rcoecksion. 
When mean percent diameter stenosis, percent area stewa 
sir and minimal lumen diameter determinations were repeated 
using videodensitometry, there were no significant differences 
belween the crows with and without reocclusion lpercent 
diameler slen&is is% vs. 701, percent area slenosis’?Q% vs. 
BB%, minimal lumcn diameter 0.8 vs. 0.9 mm, respectively). 
Infarct-dnted mt y site. Tbo right coronary artery was 
the infarel-related anew in 265 oalienls 147%). lhe kft 
anterior descending eordnwy arte; in 211 ‘(38&b’j, Ihe left 
circumflex coronal artery in 70 (13%) and thc.lcft main 
coronary artery, ~3 graft or indetermin3le vessels in 13 (2%). 
The reoeclusion rate was 5.7% in patients with right coronary 
arterv-related infarctions versus 6.2% for oalicnls with left 
ante;ior descending artery-rr:lated infetclio& and 4.3% for 
those with left circumflex Xicry-related infarctions. 
Intracvomnary lbmmbus and lesloa morpbolegy, Visible 
intramronwy lhrombus was found in 212 patients (49%) with 
arterial patency at 9Gmin angiography. Thrombus was present 
in 255 patients (49%) of the group with sustained arterial 
patency versus 17 (52%) of the group with subsequent reoc. 
elusion (p = 0.76). 
Complex lesion morphology was defined as a modified 
patcnq, 122 (61%) of the 194 who undenvcnt morphologic 
swing were found to have complex morphology compared 
with 19 (58%) of 33 of 1hc group with rcocclusion (p = 0.56). 
Adverse aegiegln~ fmxpbd@ cbaractcrislics sad IE 
caluria Table 3 lists adverse angiograpbic morphologic 
characteristics and the observed weelusion rates. These chrr- 
actcristin (determined at Sit min) were defined as minimal 
lumen diameter ,:0.5 mm, diamec; stenosis >9F%. lesion 
length >2Ll mm. visible intmeoronaty lhrombos and compkr 
lesion morphology (modified Ambrose score 1 or 2). 
Discussioo 
Thk study, which ineludes the largest group of patients with 
acute myotardiil infarction to undergo early end scheduled 
foikwup angiography, rcamtim~s the d&&y in pfcdieling 
late mr&ary ~lcomcs form early angiographj. Tb;S ancty& 
amtredii sane earlier reports (10-14) that suggested the 
utility of various early qualiilive and quantitative angio- 
graphic variabks in predig vessel reorclosion. Whereas 
many of the earlier reporh were small (range 24 to 72 
patients), this study doeumenled eariy and kale angiograpby in 
559 palicnts and was stnttikally pmercd to dcteet clinically 
imponant dticrcoecs in sevenl quantitative angkgrapbie vexi- 
abks. Our results agree with tbosc of Ellis and edleaycs (17) 
who reported the inability of 9omin angiogmphy to predict 
eoronazv reocclusion in 192 oatiints from two Tbrombolvsis 
and A&plasty in Myacardibi Infer&m (TAMI) trials. . 
l&on sewcity and rmcclnrbp tirt Our data demon- 
strate Ihat vessels with the lightest fesidtud occlw&s are not 
more likely to rcoccIudc lhan tbac with more makra~tc 
stenoscs. In feet, 59% of paticnls in tbii trial with patent 
vcwls at followup angiography had e minimal lumen diame- 
ter CO.8 mm at eartv catheterization. and 12% had a minimal 
lumen diameter cd.4 mtn. Convc&iy, 32% of patients with 
doeumentcd reowlusion had a minimal lumen diameter 
ZO.8 mm at early angiogmphy. As Tabk 3 illustrates, the 
prcscn~c of adwsc morphologic characteristiu at 9O.min 
angiography was assziated with a low risk of reoab&n 
(range 4.2% to 6.2%). This lack of relation between lesion 
weritv early after thrombolvsis and risk of reocclusion may be 
explained, (I part, by k&n remodeling in the days after 
thtombolynis (18.19) and probably represents progressive rcs- 
*_. -_a . Ambrose score of 1 or 2. In the group with continued anerial on~uon OI mromoos. 
ies (13) have suggested that complex Izsions are associated 
with earlv clinical instability after t!worbolvsis, we found no 
differen& in the incidenchof complex m&phologv between 
the groups with patent and subsequently rcoaluded infarct- 
related arteries. This observation correspords with find& m 
a report demonstrating partial resolution ot complex morpho- 
logic features over a pried of 5 to IO days after lhrombolysis 
with streptokinase (IS). We also found that early TIM1 flow 
made. intmcoronaw thrombus and infarct site were similar in 
ihe groups with pa;ent and reoccluded arteries. 
A recent analvsis from the TfMl-4 trial (201 in a smifller 
number of patients (n = 235) examinrd a&graphic predic- 
tors of reocclusion. but reoalusion was determined much 
earlier (18 to 36 h) after the tint parcncy--continning study. The 
TIM14 group also found no relation between reocclosion and 
early k&n length. minimal lumen diameter or stenosis cccxo- 
tricity, but they did repon mom frequent reocclusion in the 
presence of ulceration or clot. However. the ahsolute ditkr- 
ewe in frequency of rethrombosis was small. even though 
statistically significant, and showed that S2.6Fb of patients with 
ulceration and 89.9% of patients with thrombus at carlv 
angiography will continue to have uteridl yateocy. thus r&- 
dering the statistical significance of minimal clinical impor- 
tance. The TIM1-4 group further reported more severe pcrccnt 
stenosis (79.1% in those with subsequent reocclusion corn- 
pred with 75.4% in those whose vessels remained patent). 
‘flw st&.tkal significance of this 3.7% absolute difference ws 
reported to be p = 0.03: however, tbr small di&rence in 
percent diameter stenosis again renders the oosewation of 
little clinical value for individual patient decision making. 
Although wr group (7.21) and others (22.23) have prcvi- 
ously reported a strong relation between sobtherapeutic hep- 
arin antiiagulatian after II-PA therapy and subsequent im- 
giogmphically documented thrombotic occlusion. this relation 
could wt be examined in our study because of the very small 
number of rt-PA-treated patients with documented reoc~Iu- 
sion (n = 9). 
P&eats without Llhm.up. When there are missing values 
in a comparison such as this, legitimate concerns arise. Specif- 
ically, we speculated that the patients who did not undergo 
fdlow-up angiogmphy, and were therefore excluded from this 
analysis, might have had a dispmponianately high rate of 
reoccltion. However, a comparison of angiogmms of patients 
who died before follow-up with those of patients with docu- 
mented sustained patency revealed 111) difference in mgio- 
graphic variables at 90 min. 
Clinieaf implkatbms. Although our study demonstrates 
that standard &iographic mite& cannot he-used to predict 
which vessels will reocclude or remain patent. it is wssiblc that 
these vessels differ morphologinlly ‘but [hot angiographic 
assessment of the ruptured atherosclerotic plaque site is 
imperfect. Angioscopic studies of coronary arteries after nn- 
gioplacty have revealed diverse and intricate lumen changes 
not identified by angiography (24). Therefore, the current 
reference techmque for assessing infarct-related arteries may 
not ofccr full disclosure of the endovascokar chitecture. 
The clinical importance of the present report is the dem- 
onstration that coronary recxclusion OCCUR in vessels angio- 
graphically very similar to those that remain patent. This study 
supports the observations from the TIM1 II-A trial (25) and 
oihen (26.27) suggesting that early angiographic examination 
of a patent infarct-related artery after thrombohsis cmmot be 
osed.to identify patients whose arteries are like& to reocclode 
and who thrrefore might benefit from angioplasty or other 
intnvnscular mtewentions designed to preserve antero$rade 
Rx. 

